FORBES-TATE for EMERGENT BIOSOLUTIONS
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Re-authorization of the Pandemic and All-Hazards Preparedness Act; NDAA - provisions related to biological and chemical defense; Department of Defense appropriations for Medical Countermeasures; FDA regulatory issues; Issues related to Priority Review Voucher programs; Opioid and heroin addiction legislation, Naloxone access, co-prescribing/opioid prescribing guidelines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JERRY DRISCOLL New | — |
| KRISTINA DUNKLIN New | — |
| ELIZABETH GREER New | Chief of Staff, Rep. Allen Boyd |
| RICK MURPHY New | Chief of Staff, Senator Kelly Ayotte, April 14 - Jan. 17 |
| EDWARD C. RENO New | — |
| JEFFREY SADOSKY New | Communications Director, Senator Rob Portman Communications Director, Senator Kay Bailey Hutchison Deputy Press Secretary, Senator Mike DeWine |
| WESLEY RYAN WELCH New | Legislative Director, Senator Richard Shelby Legislative Assistant, Senator Richard Shelby Legislative Correspondent, Senator Richard Shelby |
| DERRICK M WHITE New | Deputy Communications Director, Senator Orrin |
| ZACHARY WILLIAMS New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.